1. ARV Procurement and Value For Money
Cameroon Perspectives
IAS, Paris 23 July, 2017
Pr. Sinata Koulla-Shiro

2. HIV EPIDEMIC TRENDS IN CAMEROON (2000 – 2016)
HIV Prevalence
General population: 3,8% (Spectrum 2016)
Pregnant women: 1.7% (N) to 7% (South/East)
Female sex workers: 24,3% (IBBS, 2016)
MSM: 20,6% (IBBS, 2016)
Sources: UNAIDS 2015, EPP Spectrum 2016, NACC report 2016

3. Who Buys ARV in Cameroon and through which mechanisms?
Which Mechanisms for ARV procurement in Cameroon and which actions to increase VFM?
Who Buys ARV in Cameroon and through which mechanisms?
Buys through restricted international tender for WHO pre qualified manufacturers
Buys through the ‘Pooled Procurement Mechanism’.
Buys through its project « Global Health Supply Chain- Procurement and Supply Management (GHSC -PSM) ».
key Actions to Increase VFM in ARV Procurement in Cameroon
Adoption of fixed dose combination: TDF/3TC/EFV as the 1st line treatment for adults.
Reduction of the number of pills for children by at least 50%: use of ABC/3TC (120/60 mg) instead of ABC/3TC (60/30 mg).
Introduction of new paediatric formulations easy to administer
Lopinavir/Ritonavir 40/10 mg Oral Pellets capsules in place of Lopinavir/ritonavir oral solutions,
Zidovudine/Lamivudine/Nevirapine 60/30/50 mg dispersible tablets instead of single molecular oral suspensions/solutions

4. Perspectives Streamline procurement
Tender process which includes long-term agreement (LTA) framework with pre-qualified suppliers
Strengthen patients and logistics reporting system
Produce accurate forecasts and supply plans for all HIV commodities

5. Thank you!